An ELISA for detection of apoptosis

Related Experiment Video

Updated: Nov 3, 2026

Flow Cytometric Analysis of Apoptotic Biomarkers in Actinomycin D-Treated SiHa Cervical Cancer Cells
13:53

Flow Cytometric Analysis of Apoptotic Biomarkers in Actinomycin D-Treated SiHa Cervical Cancer Cells

Published on: August 26, 2021

P Salgame1, A S Varadhachary, L L Primiano

  • 1Department of Microbiology and Immunology, Temple University School of Medicine, Philadelphia, PA 19140, USA.

Nucleic Acids Research
|February 1, 1997
PubMed

More Related Videos

Detection and Isolation of Apoptotic Bodies to High Purity12:17

Detection and Isolation of Apoptotic Bodies to High Purity

Published on: August 12, 2018

Modified Annexin V/Propidium Iodide Apoptosis Assay For Accurate Assessment of Cell Death07:34

Modified Annexin V/Propidium Iodide Apoptosis Assay For Accurate Assessment of Cell Death

Published on: April 24, 2011

Related Concept Videos

Enzyme-Linked Immunosorbent Assay01:33

Enzyme-Linked Immunosorbent Assay

In 1971, Peter Perlman and Eva Engvall developed an Enzyme-linked immunosorbent assay (ELISA or EIA). ELISA differs from western blot in that the assays are conducted in microtiter plates or in vivo rather than on an absorbent membrane.
There are many different types of ELISAs, but they all involve an antibody molecule whose constant region binds an enzyme, leaving the variable region free to bind its specific antigen.  Enzyme-substrate reaction allows the antigen to be visualized or quantified.